Copyright
©The Author(s) 2018.
World J Gastroenterol. Jul 21, 2018; 24(27): 3038-3054
Published online Jul 21, 2018. doi: 10.3748/wjg.v24.i27.3038
Published online Jul 21, 2018. doi: 10.3748/wjg.v24.i27.3038
Figure 1 PRISMA 2009 Flow diagram describing the selection of the systematic reviews reporting hepatitis C outcomes in our systematic overview.
Reasons of exclusion: 1Systematic reviews were excluded from the overview because they did not meet our inclusion criteria; 2Not a systematic review (n = 116), no hepatitis C outcomes (n = 472), not a polulation from MENA (n = 34), duplicate (n = 1), and publication in Portuguese (n = 1).
Figure 2 Hepatitis C antibody prevalence evidence gap mapping with quality assessment, general population, MENA.
MENA: Middle East and North Africa.
- Citation: Chaabna K, Cheema S, Abraham A, Alrouh H, Lowenfels AB, Maisonneuve P, Mamtani R. Systematic overview of hepatitis C infection in the Middle East and North Africa. World J Gastroenterol 2018; 24(27): 3038-3054
- URL: https://www.wjgnet.com/1007-9327/full/v24/i27/3038.htm
- DOI: https://dx.doi.org/10.3748/wjg.v24.i27.3038